论文部分内容阅读
目的探讨原发性乳腺癌2个周期新辅助化疗(NAC)后行动态增强MR成像并测量其早期血管参数变化以预测无病生存期和总生存期的可行性。材料与方法本研
Objective To investigate the feasibility of dynamic contrast-enhanced MR imaging after two cycles of neoadjuvant chemotherapy (NAC) in primary breast cancer and to measure the changes of its early vascular parameters to predict disease-free survival and overall survival. Materials and methods of this research